These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6690204)

  • 1. Changes of hemodynamics and O2 transport associated with the perfluorochemical blood substitute, Fluosol-DA.
    Nishimura N; Sugi T
    Crit Care Med; 1984 Jan; 12(1):36-8. PubMed ID: 6690204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%).
    Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC
    Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Present status of clinical studies of Fluosol-DA (20%) in Japan.
    Mitsuno T; Ohyanagi H
    Int Anesthesiol Clin; 1985; 23(1):169-84. PubMed ID: 3980104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Fluosol-DA and hetastarch on local cerebral blood flow, cortical O2 availability and computerized EEG data during cerebral ischaemia.
    Tranmer BI; Iacobacci R; Feiler S
    Neurol Res; 1990 Mar; 12(1):17-22. PubMed ID: 1692110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of various colloidal solutions during major abdominal surgery.
    Nishimura N; Hiranuma N; Sugi T
    Crit Care Med; 1983 Dec; 11(12):940-2. PubMed ID: 6196154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical use of fluosol-DA in Jehovah's Witness patients.
    Ohyanagi H; Nakaya S; Okumura S; Saitoh Y
    Artif Organs; 1984 Feb; 8(1):10-8. PubMed ID: 6703920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial Canadian experience with artificial blood (Fluosol-DA-20%) in severely anemic patients.
    Stefaniszyn HJ; Wynands JE; Salerno TA
    J Cardiovasc Surg (Torino); 1985; 26(4):337-42. PubMed ID: 4019576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluosol-DA, a perfluorochemical oxygen-transport fluid for the management of a trochanteric pressure sore in a Jehovah's Witness.
    Brown AS; Reichman JH; Spence RK
    Ann Plast Surg; 1984 May; 12(5):449-53. PubMed ID: 6742725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA.
    Tremper KK; Friedman AE; Levine EM; Lapin R; Camarillo D
    N Engl J Med; 1982 Jul; 307(5):277-83. PubMed ID: 7045667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
    Suyama T; Yokoyama K; Naito R
    Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental studies on fluosol DA administration in acute pancreatitis.
    Ohyanagi H; Ohashi O; Nakayama S; Yamamoto M; Okumura S; Saitoh Y
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):585-94. PubMed ID: 3179491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U.S. clinical studies of the treatment of anemia with fluosol-DA 20%.
    Tremper KK; Cullen BF
    Artif Organs; 1984 Feb; 8(1):19-24. PubMed ID: 6367719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions.
    Tokioka H; Miyazaki A; Fung P; Rajagopalan RE; Kar S; Meerbaum S; Corday E; Drury JK
    Circulation; 1987 Feb; 75(2):473-81. PubMed ID: 2948736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.
    Cleman M; Jaffee CC; Wohlgelernter D
    Circulation; 1986 Sep; 74(3):555-62. PubMed ID: 2943533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of Fluosol-DA in acute cerebral ischemia.
    Peerless SJ; Ishikawa R; Hunter IG; Peerless MJ
    Stroke; 1981; 12(5):558-63. PubMed ID: 6795765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of blood and Fluosol-DA for cardiopulmonary bypass.
    Rousou JA; Engelman RM; Anisimowicz L; Dobbs WA
    J Cardiovasc Surg (Torino); 1985; 26(5):447-53. PubMed ID: 4030876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].
    Oda Y; Murata T; Uchida Y; Mori K; Nagasawa S; Naruo Y; Asato R; Handa H
    No Shinkei Geka; 1982 Jun; 10(6):637-44. PubMed ID: 7121730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Fluosol on oxygen availability, regional cerebral blood flow, and infarct size in a model of temporary focal cerebral ischemia.
    Kolluri S; Heros RC; Hedley-Whyte ET; Vonsattel JP; Miller D; Zervas NT
    Stroke; 1986; 17(5):976-80. PubMed ID: 3764970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with Fluosol-DA (20%) in the United States.
    Tremper KK; Levine EM; Waxman K
    Int Anesthesiol Clin; 1985; 23(1):185-97. PubMed ID: 3884514
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Fluosol-DA (20%) on skin flap survival in rats.
    Ramasastry SS; Waterman P; Angel MF; Futrell JW
    Ann Plast Surg; 1985 Nov; 15(5):436-42. PubMed ID: 4083744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.